Antidepressant drug use and subdural hematoma risk-Reference-Cited by-同舟云学术

Antidepressant drug use and subdural hematoma risk

Published:2019-10-29 Issue:2 Volume:18 Page:318-327
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Gaist David¹²^ORCID,García Rodríguez Luis Alberto³,Hald Stine Munk¹²,Hellfritzsch Maja⁴^ORCID,Poulsen Frantz R.⁵,Halle Bo⁵,Hallas Jesper⁴,Pottegård Anton⁴^ORCID

Affiliation:

1. Department of Neurology Odense University Hospital Odense Denmark

2. Department of Clinical Research Faculty of Health Sciences University of Southern Denmark Odense Denmark

3. Centro Español Investigatión Farmacoepidemiológica (CEIFE) Madrid Spain

4. Clinical Pharmacology and Pharmacy Department of Public Health University of Southern Denmark Odense Denmark

5. Department of Neurosurgery Odense University Hospital Odense Denmark

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14658

Reference49 articles.

1. A National Survey of Traumatic Brain Injuries Admitted to Hospitals in Sweden from 1987 to 2010

2. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations

3. Association of Antithrombotic Drug Use With Subdural Hematoma Risk

4. National Patterns in Antidepressant Medication Treatment

5. Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding in patients on concurrent treatment with a selective serotonin reuptake inhibitor (SSRI) and low‐dose acetylsalicylic acid (ASA) compared with SSRI or low‐dose ASA alone—A systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2024-02-13

2. Renin-angiotensin-aldosterone system inhibitors as a risk factor for chronic subdural hematoma recurrence: A matter of debate;Journal of Stroke and Cerebrovascular Diseases;2023-10

3. Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants;Journal of Clinical Psychopharmacology;2023-05

4. Risk for intracranial hemorrhage in individuals after mild traumatic brain injury who are taking serotonergic antidepressants;Frontiers in Neurology;2022-12-07

5. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis;Annals of Medicine;2021-12-27